3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
40
Rectal Neoplasms
21
Colorectal Neoplasms
20
Colonic Neoplasms
19
Glioblastoma
13
Pancreatic Neoplasms
12
Carcinoma, Non-Small-Cell Lung
12
Stomach Neoplasms
11
Gliosarcoma
11
Central Nervous System Neoplasms
11
Esophageal Neoplasms
9
Prostatic Neoplasms
8
Lung Neoplasms
8
Head and Neck Neoplasms
8
Uterine Cervical Neoplasms
7
Carcinoma, Intraductal, Noninfiltrating
7
Adenocarcinoma Of Esophagus
7
Squamous Cell Carcinoma of Head and Neck
6
Sarcoma
6
Ovarian Neoplasms
6
Neoplasm Metastasis
6
Carcinoma, Ovarian Epithelial
6
Breast Neoplasms, Male
6
Melanoma
5
Esophageal Squamous Cell Carcinoma
5
Breast Carcinoma In Situ
5
Salivary Gland Neoplasms
4
Nasopharyngeal Carcinoma
4
Lymphoma
4
Fallopian Tube Neoplasms
4
Interventions
Blood Specimen Collection
25
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Liquid Biopsy
4
cabazitaxel
3
Surgical Procedures, Operative
3
Propofol
3
Carboplatin
3
Bevacizumab
3
Trastuzumab
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Neoadjuvant Therapy
2
Morphine
2
Laparoscopy
2
Hematologic Tests
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Capecitabine
2
Aspirin
2
Anesthesia, General
2
ribociclib
1
pertuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplastic Cells, Circulating
×
Chemotherapy, Adjuvant
×
Clear all
NCT04902937
2023-11-28
CETC
University of Jena
Recruiting
200 enrolled